← Ishga qaytish
Ushbu ish iqtibos qilgan ishlar
10 ta ish
Ish: Comparative evaluation of the single and combined effects of GLP-1 receptor agonists and SGLT2 inhibitors
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin +9
Maqola20156 iqtibosABIDapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter +11
Maqola20205 iqtibosABILiraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen +12
MaqolaOchiq kirish20164 iqtibosABISemaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso, Stephen C. Bain, Agostino Consoli +12
BoshqaOchiq kirish20164 iqtibosABI